Pakistan is set to implement a comprehensive pharmaceutical track and trace system designed to combat the widespread issue of counterfeit medicines. This initiative aims to enhance the safety and authenticity of drugs circulating in the market by enabling real-time monitoring of pharmaceutical products from manufacturing to end-user delivery. The move addresses a critical public health challenge, as fake medicines pose significant risks to patient safety and undermine trust in healthcare services.
In a significant development for the country’s healthcare sector, the track and trace system will utilize advanced technology to create a transparent supply chain. This will help regulatory authorities detect and prevent the distribution of substandard or falsified drugs, which have been linked to treatment failures and increased mortality rates. The system aligns with global best practices and reflects Pakistan’s commitment to strengthening its pharmaceutical regulatory framework.
Meanwhile, the rollout of this system is expected to have a positive impact on the pharmaceutical industry by promoting accountability and improving consumer confidence. It also supports efforts to meet international standards, potentially boosting exports and attracting investment. Ultimately, this initiative represents a crucial step toward safeguarding public health and ensuring that patients receive genuine, effective medications across Pakistan.
